Abstract
Antiplatelet therapy reduces the rate of cardiovascular events in patients with atherosclerotic vascular disease. The aim of this meta-analysis is to assess the effect of the combination of ASA/plavix compared with ASA alone in the prevention of stoke in patients with symptomatic cardiovascular disease.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
